ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease whose subtypes are determined by the presence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); different subtypes are important for clinical management [99].